Effects of Continuous Nerve Block vs Single Injection Block With PCA vs PCA on Pain and Function After Knee Replacement
PCA
Effects of Continuous Femoral Nerve Block Versus Single-Injection Femoral Nerve Block With Intravenous Patient Controlled Analgesia Versus Intravenous Patient Controlled Analgesia on Knee Pain and Function After Total Knee Replacement
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to compare the effectiveness of three analgesia techniques on pain relief and functional recovery after knee replacement: continuous femoral nerve block vs single-injection femoral nerve block with intravenous patient controlled analgesia vs intravenous patient controlled analgesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable pain
Started Jul 2009
Longer than P75 for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 22, 2010
CompletedFirst Posted
Study publicly available on registry
August 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedMay 13, 2016
August 1, 2010
1.9 years
August 22, 2010
May 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of patients with significant pain on movement on day 1 post surgery
Post op day 1
Secondary Outcomes (1)
Functional recovery
During hospitalization, week 2, week 12
Study Arms (3)
Continuous Femoral Nerve Block
EXPERIMENTALSingle-Inj Nerve Block with IV PCA
ACTIVE COMPARATORIV PCA
ACTIVE COMPARATORInterventions
20mls of 0.25% Bupivacaine with 1/400,000 adrenaline (2.5mcg/ml) If catheter localized to \< 1.0mA, 0.1mS with patella twitch, start Bupivacaine 0.125% 4ml/hr. If unable to get twitch through catheter in final location or twitch at current ≥ 1.0m/A, start Bupivacaine 0.125% 6ml/hr.
Eligibility Criteria
You may qualify if:
- years and above
- Osteoarthritis
- Primary unilateral total knee replacement
- No other lower extremity joint disease
- ASA I-III
- Body mass index \< 35
- No severe cardiac or pulmonary diseases
- No chronic narcotic therapy or illicit drug use
- Mentally competent to understand study procedures and use of pain scales
- Able to provide informed consent
You may not qualify if:
- Any cause for knee replacement other than osteoarthritis
- Total knee revision
- Any contraindication for femoral block
- Abnormal coagulation studies
- Thrombocytopenia less than 100,000/cc
- Known hepatic or renal insufficiency
- Neurological disease involving lower extremities
- Major surgery during the last 2 weeks pre-operatively
- History of allergy to study medications
- History of post-operative bleeding over 2000 cc/24 hours
- History of opioid or alcohol abuse
- Currently taking or has taken opioid \> 30 consecutive days of daily use at a daily dose \> 15mg morphine, within the past 2 weeks prior to surgery
- Previously has not responded to opioid analgesics for treatment of pain
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tan Tock Seng Hospital
Singapore, Singapore
Related Publications (1)
Chan EY, Teo YH, Assam PN, Fransen M. Functional discharge readiness and mobility following total knee arthroplasty for osteoarthritis: a comparison of analgesic techniques. Arthritis Care Res (Hoboken). 2014 Nov;66(11):1688-94. doi: 10.1002/acr.22361.
PMID: 24782108DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ee Yuee Chan
Tan Tock Seng Hospital
- PRINCIPAL INVESTIGATOR
Nelson Chua
Tan Tock Seng Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
August 22, 2010
First Posted
August 24, 2010
Study Start
July 1, 2009
Primary Completion
June 1, 2011
Study Completion
December 1, 2011
Last Updated
May 13, 2016
Record last verified: 2010-08